Press Releases for CYTX

Press Releases
Cytori Reports 3rd Quarter 2009 Financial Results
StockPreacher.com Issues Trading Outlook for Advanced Cell Technology Inc.
Cytori Reports 2nd Quarter 2009 Financial Results
Cytori Therapeutics 2nd Quarter Financial Results Conference Call & Shareholder Letter
Cytori Therapeutics to Webcast Second Quarter Financial Results on August 10, 2009
Cytori Comments on Patent Appeal
Cytori’s Celution® 700 System to be Regulated as a Medical Device by U.S. FDA
Jesup & Lamont Announces Presenting LifeTech Companies and Former FDA Commissioner at Annual Growth Stock & National Sales Conference
Cytori Expands Patent Protection for the Celution® System and Uses for Adipose Derived Stem and Regenerative Cells
Cytori Expands Patent Protection for the Celution® System and Uses for Adipose Derived Stem and Regenerative Cells
InvestorSoup.com Researches: Oracle, Comcast, Cytori, Wal-Mart, Abbot and GT Solar
Cytori Receives Equity Commitment; Investment Fund to Purchase Up to 7.15 Million Shares Over Next 12 Months
Cytori to Present at Two Upcoming Investor Conferences
Cytori Reports Publication of Cardiovascular Preclinical Study; Adipose Stem & Regenerative Cells Improve Function in Heart Attack Model
Cytori Completes Enrollment in First Adipose Stem & Regenerative Cell Therapy Trial for Chronic Heart Disease
Cytori Reports First Quarter 2009 Financial Results
Cytori and GE Healthcare Form Partnership to Commercialize StemSource Products in the U.S.
Cytori Therapeutics to Raise $4.2 Million Through a Private Placement
Cytori Therapeutics to Webcast First Quarter Financial Results on May 11, 2009
Cytori to Host Investor Call with European Physicians on Cell Enhanced Reconstruction
Cytori Receives U.S. Patent Allowance for Key Commercial Products
Cytori to Present at the 16th Annual Future Leaders in the Biotech Industry Conference on April 2, 2009
Cytori Therapeutics Closes Previously Announced $10 Million Financing
Cytori Receives Cell Banking Patent for the Celution(R) System
Cytori Receives Cell Banking Patent for the Celution® System
Cytori Therapeutics to Raise $10 Million in Registered Direct Offering
Zacks Bull & Bear of the Day Highlights: Cytori Therapeutics, Freddie Mac, Citigroup, Bank of America and Comerica
Zacks Analyst Blog Highlights: Ciena Corp, Kimberly-Clark, Cytori Therapeutics Inc, Merck & Co and Schering-Plough Corp.
Cytori Stem & Regenerative Cell Heart Attack Trial Feasible & Safe
Cytori Reports Year End 2008 Results; Reviews 2008 Progress and 2009 Business Objectives
Zacks Analyst Blog Highlights: Morton's Restaurant Group, Cytori Therapeutics, Big 5 Sporting Goods, DeVry, Inc. And Sonic Innovations
Cytori Therapeutics to Webcast 2008 Earnings Conference Call
Adipose-Derived Stem and Regenerative Cells Prevent Mortality and Reduce Kidney Damage in Preclinical Study
Cytori Patent Allowance Expands Celution® System Protection for Adipose Stem & Regenerative Cell Processing
First Patient Treated in Adipose Stem & Regenerative Cell Study for Stress Urinary Incontinence
Cytori Forms Commercialization Partnership with GE Healthcare
Cytori Expands Patent Protection for Celution® Stem & Regenerative Cell Processing System
Zacks Analyst Blog Highlights: Celgene Corp., Cytori Therapeutics, CAI International, Inc., Sinopec and Smith Micro Software, Inc.
Composition of Matter Patent Covering Adipose-Derived Stem and Progenitor Cells Issued
Adipose Stem & Regenerative Cell Clinical Study Underway for Treatment of Chronic Radiation Injury
Cytori Demonstrates Benefit of Adipose-Derived Stem and Regenerative Cells in Spinal Disc Repair in Preclinical Study
Cytori to Present at the Piper Jaffray 20th Annual Healthcare Conference on December 2
Cytori Strengthens European Union Sales, Training and Service Operations
Seven Investigator-Initiated Clinical Studies Announced
Cytori Receives First StemSource(R) Cell Bank Order from Green Hospital Supply
Cytori Achieves 2nd Consecutive Quarter of Celution(R) System-Based Revenue Growth
Cytori to Webcast Two Upcoming Events
Cytori to Present at AeA Classic Financial Conference on November 4
Cytori to Present at 2008 BIOCOM Investor Conference on October 27
Cytori Secures $15 Million Loan Facility Led by GE Healthcare Financial Services
Composition of Matter Patent Allowance Covers Adipose-Derived Stem and Progenitor Cells
Cytori Receives Two Patent Allowances Related to Uses of the Celution(R) System Output
Cytori Receives Key Patent for its Cosmetic & Reconstructive Surgery Product
Zacks Analyst Blog Highlights: Unilever, Cytori Therapeutics Inc., Pfizer Inc., UST, Inc. And Altria Group.
Surgeons Report Clinical Experience Using Cytori's Celution(R) 800/CRS System with 52 Patients
Cytori to Present at the Noble Financial Equity Conference on August 18
Cytori Therapeutics 2nd Quarter Results Conference Call to Begin at 10:30 AM
Cytori to Raise $17 Million in Private Placement with Olympus and Institutional Investors
Cytori Reports Second Quarter Financial Results; Strong Growth in Product Orders and Celution(R) Revenue
Cytori Therapeutics to Webcast 2nd Quarter Results on August 8, 2008
Cytori Enters Binding Letter of Intent for StemSource(R) Cell Bank Sales for Singapore
Cytori Receives U.S. Patent Allowance for Protecting Cosmetic & Reconstructive Surgery Product Line
Cytori Sells First European Union StemSource(R) Bank; Industry Leading Biohellenika of Greece Acquires Exclusive Rights
U.S. Patent on Cytori's Celution(R) System Technology Issued; Celution(R) System Commercialization not Impacted by Recent 6,777,231 Patent Inventorship Decision
Cytori Set to Join Russell 3000 Index
Cytori Selected by Fraunhofer Society to Develop New Stem and Regenerative Cell-Based Treatments for Stroke
University of California Loses Rights to '231 Patent Licensed to Cytori; Ruling Unrelated to Celution(R) System Family of Products
Cytori Receives Patent on Core Celution(R) System Technology
Cytori and Green Hospital Supply Expand StemSource(R) Cell Bank Commercialization Partnership
SectorWatch.biz Issues MarketStats on CYTX, HNSN, MDT, SYK, and JNJ
Three Month Results Reported from Stem & Regenerative Cell Breast Augmentation Study - May 27 2008 12:55AM
Cytori to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference - Jun 1 2008 5:15PM
Cytori Reports First Celution(R) System Revenues During the First Quarter; Provides Update on Celution(R) System Commercialization - Jun 1 2008 5:15PM
Cytori Begins Breast Reconstruction Study in Europe - Jun 1 2008 5:14PM
Cytori Closes 2nd Half of $12 Million Equity Agreement with Green Hospital Supply
Cytori Therapeutics to Webcast 1st Quarter Results on May 9, 2008
Nagasaki University Awarded Clinical Research Grant to Study Cell-Enhanced Reconstruction in HIV Therapy-Induced Facial Atrophy Using Celution(R) 800 System
Enrollment Completed for Investigator-Initiated Stem & Regenerative Cell Breast Augmentation Study in Japan